DRIADA SHIPS ONLY TO GERMANY, UK, FRANCE, ITALY, SPAIN, POLAND, ROMANIA, NETHERLANDS, BELGUIM, CZECH REPUBLIC, GREECE, PORTUGAL, HUNGARY, BULGARIA, SLOVAKIA, CROTIA, SOLVENIA, LUXEMBOURG, ANDORRA, MONACO and SAN MARINO.
DO NOT SHIP TO ISLAND AREAS OF EUROPE THAT ARE PART OF THE EU SUCH AS CANARY ISLANDS, SWITZERLAND, AUSTRIA, ESTONIA, LATVIA , LITHUANIA , ICELAND SWEDEN, NORWAY, DENMARK, FINLAND, GIBRALTAR, SOUTH KOREA, ISRAEL, AUSTRALIA, USA and CANADA!!!
We newly started our product review feature.
Be the first to comment on this product.
Please login to comment on this product.
RAD140 is a new substance that is still being studied in pharmaceutical trials. RAD140 was developed by Radius Pharmaceuticals in the late 2000s as a potential therapeutic agent to prevent muscle wasting in terminally ill patients. It is currently being investigated as a therapeutic agent for breast cancer patients. RAD140 has excellent pharmacokinetic properties and is powerful anabolic. It has similar anabolic effects to LGD4033 and also appears to be a partial agonist in prostate tissue. That is, it can protect the prostate from enlargement when exposed to testosterone or any of its derivatives. Like, S4, it looks like it could be a great addition to any steroid complex to protect against prostate hyperplasia. In addition, RAD140 lowers lipid levels (LDL, HDL, Tryglicerides) without increasing liver enzymes.